103 related articles for article (PubMed ID: 22689615)
1. Non-small cell bronchial carcinoma metastasizing into a prolactin-producing pituitary adenoma.
Rotondo F; Kovacs K; Macdonald RL; Prud'homme GJ; Latta E; Munoz D
Int J Surg Pathol; 2013 Feb; 21(1):68-71. PubMed ID: 22689615
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of thalidomide on the growth, secretory function and angiogenesis of estrogen-induced prolactinoma in Fischer 344 rats.
Stepień H; Lawnicka H; Mucha S; Wagrowska-Danilewicz M; Stepień B; Siejka A; Komorowski J
Life Sci; 2006 Sep; 79(18):1741-8. PubMed ID: 16846617
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of antivascular endothelial growth factor strategies in experimental dopamine-resistant prolactinomas.
Luque GM; Perez-Millán MI; Ornstein AM; Cristina C; Becu-Villalobos D
J Pharmacol Exp Ther; 2011 Jun; 337(3):766-74. PubMed ID: 21406548
[TBL] [Abstract][Full Text] [Related]
4. Thrombotic thrombocytopenic purpura associated with a prolactin-producing pituitary adenoma.
Kovacs K; Garvey MB
Am J Hematol; 2003 Sep; 74(1):55-9. PubMed ID: 12949891
[TBL] [Abstract][Full Text] [Related]
5. Giant prolactinoma: where's the prolactin?
Tailor C; Teo I; Sorisky A
Clin Neurol Neurosurg; 2011 Nov; 113(9):810-2. PubMed ID: 21906866
[No Abstract] [Full Text] [Related]
6. Prolactin-producing pituitary adenoma associated with prolactin cell hyperplasia.
Vidal S; Horvath E; Syro LV; Uribe H; Cohen S; Kovacs K
Endocr Pathol; 2002; 13(2):157-65. PubMed ID: 12165665
[TBL] [Abstract][Full Text] [Related]
7. Effects of somatostatin on vascular endothelial growth factor (VEGF) secretion from non-functioning pituitary tumoral cells incubated in vitro.
Ławnicka H; Pisarek H; Kunert-Radek J; Pawlikowski M
Neuro Endocrinol Lett; 2008 Feb; 29(1):113-6. PubMed ID: 18283262
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic study of 123 cases of prolactin-secreting pituitary adenomas with special reference to multihormone production and clonality of the adenomas.
Ma W; Ikeda H; Yoshimoto T
Cancer; 2002 Jul; 95(2):258-66. PubMed ID: 12124824
[TBL] [Abstract][Full Text] [Related]
9. Neuronal differentiation and expression of neural epitopes in pituitary adenomas.
Johnson MD; Fan X; Bourne P; Walters D
J Histochem Cytochem; 2007 Dec; 55(12):1265-71. PubMed ID: 17875653
[TBL] [Abstract][Full Text] [Related]
10. Prolactin secreting pituitary carcinoma.
Petterson T; MacFarlane IA; MacKenzie JM; Shaw MD
J Neurol Neurosurg Psychiatry; 1992 Dec; 55(12):1205-6. PubMed ID: 1479402
[TBL] [Abstract][Full Text] [Related]
11. Prolactin-producing pituitary adenoma with incomplete neuronal transformation: an intermediate adenoma-neuronal tumor.
Thodou E; Kontogeorgos G; Horvath E; Kovacs K
Acta Neuropathol; 2004 Aug; 108(2):115-20. PubMed ID: 15173951
[TBL] [Abstract][Full Text] [Related]
12. Metallothionein isoform 3 gene is differentially expressed in corticotropin-producing pituitary adenomas.
Giorgi RR; Correa-Giannella ML; Casarini AP; Machado MC; Bronstein MD; Cescato VA; Giannella-Neto D
Neuroendocrinology; 2005; 82(3-4):208-14. PubMed ID: 16601360
[TBL] [Abstract][Full Text] [Related]
13. Pituitary prolactin producing adenoma with ossification: a rare histological variant and review of literature.
Ke C; Deng Z; Lei T; Zhou S; Guo DS; Wan J; Wu S
Neuropathology; 2010 Apr; 30(2):165-9. PubMed ID: 19737358
[TBL] [Abstract][Full Text] [Related]
14. Hormone production in pituitary adenomas following external irradiation: an experimental study in rats.
Friedrich RE; Saeger W; Laas R; Friedrich SB
Anticancer Res; 2000; 20(6D):5165-70. PubMed ID: 11326689
[TBL] [Abstract][Full Text] [Related]
15. Increased micronucleus, nucleoplasmic bridge, nuclear bud frequency and oxidative DNA damage associated with prolactin levels and pituitary adenoma diameters in patients with prolactinoma.
Bitgen N; Donmez-Altuntas H; Bayram F; Cakir I; Hamurcu Z; Diri H; Baskol G; Senol S; Durak AC
Biotech Histochem; 2016; 91(2):128-36. PubMed ID: 26720589
[TBL] [Abstract][Full Text] [Related]
16. Malignant prolactinoma: a rare case report.
Trivedi P; Gupta A; Pasricha S; Patel D
Neurol India; 2010; 58(5):778-80. PubMed ID: 21045511
[TBL] [Abstract][Full Text] [Related]
17. Do the limits of serum prolactin in disconnection hyperprolactinaemia need re-definition? A study of 226 patients with histologically verified non-functioning pituitary macroadenoma.
Karavitaki N; Thanabalasingham G; Shore HC; Trifanescu R; Ansorge O; Meston N; Turner HE; Wass JA
Clin Endocrinol (Oxf); 2006 Oct; 65(4):524-9. PubMed ID: 16984247
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical analysis of GH-producing adenomas--with special emphasis on plurihormonality of individual tumor cells by double staining.
Inada K; Oda K; Utsunomiya H; Itoh J; Osamura RY
Tokai J Exp Clin Med; 1992 Dec; 17(5-6):213-22. PubMed ID: 1285309
[TBL] [Abstract][Full Text] [Related]
19. Estradiol stimulates vascular endothelial growth factor and interleukin-6 in human lactotroph and lactosomatotroph pituitary adenomas.
Onofri C; Carbia Nagashima A; Schaaf L; Feirer M; Lohrer P; Stummer W; Berner S; Chervin A; Goldberg V; Stalla GK; Renner U; Arzt E
Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):18-23. PubMed ID: 14758567
[TBL] [Abstract][Full Text] [Related]
20. Induction of GH, PRL, and TSH beta mRNA by transfection of Pit-1 in a human pituitary adenoma-derived cell line.
Miyai S; Yoshimura S; Iwasaki Y; Takekoshi S; Lloyd RV; Osamura RY
Cell Tissue Res; 2005 Nov; 322(2):269-77. PubMed ID: 16133148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
